Cantex Pharmaceuticals, Inc. - Net Worth and Insider Trading

Cantex Pharmaceuticals, Inc. Net Worth

The estimated net worth of Cantex Pharmaceuticals, Inc. is at least $3 Million dollars as of 2023-09-26. Cantex Pharmaceuticals, Inc. is the 10% Owner of Chimerix Inc and owns about 3,500,000 shares of Chimerix Inc (CMRX) stock worth over $3 Million. Details can be seen in Cantex Pharmaceuticals, Inc.'s Latest Holdings Summary section.

Transaction Summary of Cantex Pharmaceuticals, Inc.


Cantex Pharmaceuticals, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cantex Pharmaceuticals, Inc. owns 1 companies in total, including Chimerix Inc (CMRX) .

Click here to see the complete history of Cantex Pharmaceuticals, Inc.’s form 4 insider trades.

Insider Ownership Summary of Cantex Pharmaceuticals, Inc.

Ticker Comapny Transaction Date Type of Owner
CMRX Chimerix Inc 2019-07-26 10 percent owner

Cantex Pharmaceuticals, Inc. Latest Holdings Summary

Cantex Pharmaceuticals, Inc. currently owns a total of 1 stock. Cantex Pharmaceuticals, Inc. owns 3,500,000 shares of Chimerix Inc (CMRX) as of September 14, 2021, with a value of $3 Million.

Latest Holdings of Cantex Pharmaceuticals, Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMRX Chimerix Inc 2021-09-14 3,500,000 0.98 3,430,000

Holding Weightings of Cantex Pharmaceuticals, Inc.

Cantex Pharmaceuticals, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Cantex Pharmaceuticals, Inc. has made a total of 1 transactions in Chimerix Inc (CMRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Chimerix Inc is the sale of 6,500,000 shares on September 14, 2021, which brought Cantex Pharmaceuticals, Inc. around $37 Million.

Insider Trading History of Cantex Pharmaceuticals, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cantex Pharmaceuticals, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cantex Pharmaceuticals, Inc. Ownership Network

Ownership Network List of Cantex Pharmaceuticals, Inc.

No Data

Ownership Network Relation of Cantex Pharmaceuticals, Inc.

Cantex Pharmaceuticals, Inc. Owned Company Details

What does Chimerix Inc do?

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Who are the key executives at Chimerix Inc?

Cantex Pharmaceuticals, Inc. is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Medical Officer Allen S. Melemed , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .

Chimerix Inc (CMRX) Insider Trades Summary

Over the past 18 months, Cantex Pharmaceuticals, Inc. made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net purchase of 28,000 shares made by Martha J Demski , and a net sale of 7,630 shares made by David Jakeman .

In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,630 shares of Chimerix Inc (CMRX) were sold and 198,750 shares were bought by its insiders, resulting in a net purchase of 191,120 shares.

Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.


Chimerix Inc Insider Transactions

No Available Data

Cantex Pharmaceuticals, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Cantex Pharmaceuticals, Inc.. You might contact Cantex Pharmaceuticals, Inc. via mailing address: 1792 Bell Tower Lane, Suite 222, Weston Fl 33326.

Discussions on Cantex Pharmaceuticals, Inc.

No discussions yet.